Related Experiment Videos
Juvenile systemic scleroderma
1Dipartimento di Scienze Pediatriche, Università di Pavia, IRCCS Policlinico S. Matteo, 27100, Pavia, Italy. amartini@smatteo.pv.it
Current Rheumatology Reports
|September 21, 2001
Summary
Systemic scleroderma in children, though rare, may benefit from new treatments developed for adults. Research suggests microchimerism
Area of Science:
- Pediatric rheumatology
- Immunology
- Genetics
Background:
- Systemic scleroderma in children is rare and mimics adult disease.
- Recent advances in understanding adult systemic scleroderma pathogenesis and treatment have emerged.
Purpose of the Study:
- To explore the potential value of novel etiopathogenetic and therapeutic approaches for childhood-onset systemic scleroderma.
Main Methods:
- Review of recent findings in adult systemic scleroderma research.
- Analysis of microchimerism's role in disease pathogenesis.
- Evaluation of immunoablation and stem cell rescue as potential therapies.
Main Results:
- Microchimerism is implicated in the pathogenesis of systemic scleroderma.
- Immunoablation followed by stem cell rescue shows therapeutic promise in adults.
Conclusions:
- Emerging etiopathogenetic insights and therapeutic strategies for adult systemic scleroderma may be applicable to pediatric cases.
- Further investigation into microchimerism and stem cell therapies for childhood-onset disease is warranted.